epibatidine has been researched along with succinylcholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lembeck, F | 1 |
| Dart, MJ; Holladay, MW; Lynch, JK | 1 |
1 review(s) available for epibatidine and succinylcholine
| Article | Year |
|---|---|
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
Topics: Acetylcholine; Animals; Binding Sites; Dopamine; Drug Design; Humans; Molecular Structure; Nervous System; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Structure-Activity Relationship | 1997 |
1 other study(ies) available for epibatidine and succinylcholine
| Article | Year |
|---|---|
Epibatidine: high potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors.
Topics: Animals; Auditory Pathways; Brain; Bridged Bicyclo Compounds, Heterocyclic; Decerebrate State; Female; Ganglia, Sympathetic; Guinea Pigs; Ileum; In Vitro Techniques; Male; Mice; Muscle Contraction; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Nicotine; Nicotinic Agonists; Oculomotor Muscles; Pain Threshold; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Succinylcholine; Sympathetic Fibers, Postganglionic | 1999 |